Cabaletta Bio, Inc. (CABA)
2.91
-0.36
(-11.01%)
USD |
NASDAQ |
Sep 09, 16:00
2.96
+0.05
(+1.72%)
After-Hours: 05:41
Cabaletta Bio Total Liabilities (Quarterly) : 46.14M for June 30, 2026
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 46.14M |
| March 31, 2026 | 44.84M |
| December 31, 2025 | 58.23M |
| September 30, 2025 | 50.29M |
| June 30, 2025 | 46.02M |
| March 31, 2025 | 43.59M |
| December 31, 2024 | 36.65M |
| September 30, 2024 | 30.17M |
| June 30, 2024 | 17.90M |
| March 31, 2024 | 18.74M |
| December 31, 2023 | 17.45M |
| September 30, 2023 | 12.36M |
| June 30, 2023 | 10.50M |
| March 31, 2023 | 11.80M |
| December 31, 2022 | 12.45M |
| September 30, 2022 | 5.801M |
| Date | Value |
|---|---|
| June 30, 2022 | 6.486M |
| March 31, 2022 | 6.935M |
| December 31, 2021 | 8.38M |
| September 30, 2021 | 6.023M |
| June 30, 2021 | 5.601M |
| March 31, 2021 | 3.969M |
| December 31, 2020 | 5.18M |
| September 30, 2020 | 4.265M |
| June 30, 2020 | 3.263M |
| March 31, 2020 | 3.256M |
| December 31, 2019 | 3.147M |
| September 30, 2019 | 101.02M |
| June 30, 2019 | |
| March 31, 2019 | |
| December 31, 2018 | 44.86M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| Agenus, Inc. | 378.54M |
| Amgen, Inc. | 83.95B |
| Anika Therapeutics, Inc. | 46.19M |
| BioCryst Pharmaceuticals, Inc. | 1.012B |
| Imunon, Inc. | 10.80M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 256.73M |
| Shareholders Equity (Quarterly) | 210.59M |
| Debt to Equity Ratio | 0.1221 |
| Current Ratio | 5.789 |
| Net Debt Paydown Yield | 0.12% |